Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017788

« Back to Dashboard

NDA 017788 describes RIMSO-50, which is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. Additional details are available on the RIMSO-50 profile page.

The generic ingredient in RIMSO-50 is dimethyl sulfoxide. There are seventy-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimethyl sulfoxide profile page.

Summary for 017788

Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 017788

Suppliers and Packaging for NDA: 017788

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIMSO-50 dimethyl sulfoxide SOLUTION;INTRAVESICAL 017788 NDA Mylan Institutional LLC 67457-177 67457-177-50 1 VIAL, GLASS in 1 CARTON (67457-177-50) > 50 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVESICALStrength50%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Expired Orange Book Patents for NDA: 017788

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan InstitutionalRIMSO-50dimethyl sulfoxideSOLUTION;INTRAVESICAL017788-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: